Endometrial Cancer
Conditions
Brief summary
The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.
Detailed description
Primary Objectives: 1. To develop an EC educational tool for systemic therapy of endometrial cancer. 2. To explore: 1. Acceptability of incorporating the EC educational tool into routine clinical care through a pilot study with EC patients 2. Feasibility, acceptability and the appropriateness of incorporating the EC educational tool into routine clinical care through a pilot study with health care providers of EC patients 3. To estimate the effectiveness of the EC educational tool with EC patients through a pilot study of EC patients and their health care providers.
Interventions
OTHERInteractive Educational Website
Participants will utilize website to access educational content, knowledge measure, values survey, and cognitive and usability testing
Sponsors
M.D. Anderson Cancer Center
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients: Study Objective 1 (Part A-C see Figure 2) 1. Women who have been diagnosed with endometrial cancer 2. Must be at least 18 years old 3. Must read and speak English or Spanish 4. Must provide written informed consent Study Objectives 2 and 3 (Pilot Study) 1. Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment 2. Must be at least 18 years old 3. Must read and speak English or Spanish 4. Must provide written informed consent. Physicians: Study Objective 1 (Qualitative Interviews) 1. Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions 2. Must be able to speak and read English 3. Must provide written informed consent Healthcare Providers: Study Objectives 2 and 3 (Pilot Study) 1. Healthcare Providers (including but not limited to gynecologic oncologists and APPs) who practice at MDA, the HALs or LBJ Hospital who provide care to women diagnosed with endometrial cancer 2. Must be able to speak and read English 3. Must provide written informed consent
Exclusion criteria
None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety and Adverse Events (AEs) | Through study completion; an average of 1 year | Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Countries
United States
Contacts
CONTACTLarissa Meyer, MD, MPH
PRINCIPAL_INVESTIGATORLarissa Meyer, MD, MPH
UT MD Anderson
Outcome results
None listed